Cancer metastasis due to the inhibitory effect of NIFK on the binding of RUNX1 to the CK1α promoter region, as demonstrated by our study, represents a novel tumor progression mechanism that merits further investigation. The gene discussed is CSNK1A1; the disease is cancer.